Stericycle, Inc. (NASDAQ:SRCL) Shares Sold by Truist Financial Corp

Truist Financial Corp cut its position in shares of Stericycle, Inc. (NASDAQ:SRCL) by 50.1% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 3,515 shares of the business services provider’s stock after selling 3,523 shares during the quarter. Truist Financial Corp’s holdings in Stericycle were worth $204,000 at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of SRCL. Clearstead Trust LLC purchased a new stake in Stericycle in the 1st quarter worth approximately $25,000. GAMMA Investing LLC grew its position in shares of Stericycle by 170.9% in the first quarter. GAMMA Investing LLC now owns 818 shares of the business services provider’s stock valued at $43,000 after purchasing an additional 516 shares during the period. Headlands Technologies LLC acquired a new position in Stericycle in the first quarter valued at $44,000. International Assets Investment Management LLC acquired a new position in Stericycle in the second quarter valued at $45,000. Finally, Quest Partners LLC lifted its position in Stericycle by 4,172.7% during the second quarter. Quest Partners LLC now owns 940 shares of the business services provider’s stock worth $55,000 after buying an additional 918 shares during the period. Institutional investors and hedge funds own 98.82% of the company’s stock.

Wall Street Analyst Weigh In

Separately, StockNews.com began coverage on Stericycle in a report on Saturday. They issued a “hold” rating for the company. One research analyst has rated the stock with a sell rating, four have issued a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $74.00.

Stericycle Trading Up 0.0 %

Shares of SRCL opened at $60.90 on Friday. Stericycle, Inc. has a twelve month low of $37.78 and a twelve month high of $61.77. The firm has a market capitalization of $5.65 billion, a P/E ratio of -276.82, a price-to-earnings-growth ratio of 3.32 and a beta of 1.11. The company has a current ratio of 1.13, a quick ratio of 1.13 and a debt-to-equity ratio of 0.55. The stock’s fifty day simple moving average is $60.35 and its 200 day simple moving average is $56.03.

Stericycle (NASDAQ:SRCL) last released its quarterly earnings data on Thursday, July 25th. The business services provider reported $0.61 EPS for the quarter, topping analysts’ consensus estimates of $0.57 by $0.04. The company had revenue of $661.60 million for the quarter, compared to the consensus estimate of $672.07 million. Stericycle had a return on equity of 7.94% and a net margin of 1.37%. On average, equities research analysts forecast that Stericycle, Inc. will post 2.29 earnings per share for the current year.

Stericycle Profile

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.